Tyrosine kinase receptors as molecular targets in pheochromocytomas and paragangliomas
Clarissa Araujo Cassol, Daniel A. Winer, Wei Liu et al. · Modern Pathology · 2014
Cited by 20 works. doi:10.1038/modpathol.2013.233 Open-access PDF
Authors
References
- World Health Organization Classification of Tumours
- TM4: A Free, Open-Source System for Microarray Data Management and Analysis
- STRING 8--a global view on proteins and their functional interactions in 630 organisms
- Pathology and genetics of tumours of endocrine organs
- VEGF-targeted therapy: mechanisms of anti-tumour activity
- A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas
- An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis
- Clinical Risk Factors for Malignancy and Overall Survival in Patients with Pheochromocytomas and Sympathetic Paragangliomas: Primary Tumor Size and Primary Tumor Location as Prognostic Indicators
- Molecular Pathways: Fibroblast Growth Factor Signaling: A New Therapeutic Opportunity in Cancer
- Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele.